Skip to main content
GUTS logo

Fractyl Health, Inc.

GUTSNASDAQHealthcareBiotechnology

$1.07Today:- (-)1Y −18.12%

As of Oct 26, 2026 close

Market cap
$169.75M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.38$12.24
Volume (live)
-
Avg. volume (3M)
776.58K

Fractyl Health (GUTS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Fractyl Health used $90.33M of cash in operating activities and spent $557.00K on capital expenditures. That left free cash flow of −$90.89M.

Fractyl Health Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Fractyl Health, Inc. (GUTS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-140.95-68.69-77.09-77.09-46.45-38.74-30.48-30.59
Depreciation & Amortization1.130.680.290.290.450.680.770.89
Stock Based Compensation6.6814.434.304.303.142.091.632.52
Change in Working Capital-0.409.590.990.99-1.241.71-3.51-0.82
Change in Accounts Receivable0.000.02-0.02-0.020.000.000.000.00
Change in Inventory0.070.00-0.07-0.070.000.000.000.00
Change in Accounts Payable-1.672.69-0.43-0.430.010.67-0.300.00
Change in Other Working Capital1.206.881.510.97-2.321.05-3.20-0.82
Other Operating Activities43.21-21.5228.7026.20-2.320.800.520.27
Net Cash from Operating Activities-90.33-65.52-42.82-42.82-46.24-33.46-31.07-27.73
Investing Activities
Capital Expenditures-0.56-1.77-0.36-0.36-0.06-0.050.00-0.10
Net Cash from Investing Activities-0.56-1.77-0.36-0.36-0.06-0.050.00-0.10
Financing Activities
Debt Repayment-0.46-0.1928.35-0.08-16.05-0.01-0.0114.95
Common Stock Issued105.42103.700.000.050.320.000.020.22
Other Financing Activities0.00-2.28-0.91-0.960.0099.8954.400.22
Net Cash from Financing Activities104.96101.2327.4427.444.3599.8854.3915.16
Summary
Effect of Forex Changes on Cash0.000.000.00--4.260.000.000.00
Net Change in Cash14.0833.94-15.75-15.75-41.9566.3723.32-12.66
Cash at Beginning of Period71.7237.7853.5253.5295.4729.115.7918.46
Cash at End of Period85.8071.7237.7837.7853.5295.4729.115.79
Free Cash Flow-90.89-67.29-43.18-43.18-46.30-33.51-31.08-27.83
Supplemental Disclosures
Interest Paid-3.13-0.760.011.031.04-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Fractyl Health Cash Flow

What is Fractyl Health's free cash flow?

Fractyl Health had negative free cash flow of $90.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$90.33M minus $557.00K of capital expenditures.

How much does Fractyl Health spend on capital expenditures?

Fractyl Health spent $557.00K on capital expenditures in fiscal 2025, compared with $1.76M a year earlier.

Does Fractyl Health pay dividends or buy back shares?

Fractyl Health's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition